ResearcherUniversity of PaduaActive in the last 2 years
Umberto Cillo
Matched on ORCID iD 0000-0002-2310-0245; OpenAlex author ID A5021781945, A5137175639. Sources: OpenAlex.
Their work
- Papers
- 8 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 14
2023: 1 paper · 2024: none · 2025: 1 paper · 2026: 6 papers
Papers 8
- Pancreatic cancer surgery in Italy: an updated snapshot from a national multicentre analysis of outcomes by hospital volume. Co-author DOI 10.1007/s13304-026-02813-5↗
- Multicenter IGoMIPS Registry-based analysis of robotic versus laparoscopic approach to left pancreatectomy for pancreatic cancer. Co-author DOI 10.1007/s13304-026-02831-3↗
- The projected rise of pancreatic cancer mortality in Italy: forecasts until 2035. Co-author DOI 10.1007/s13304-026-02862-w↗
- Conversion surgery vs. standard of care in pancreaTic cancer oligometastatic to the liver (SONAR: Surgery in Oligometastatic paNcreatic cAnceR) a randomized co… Last author DOI 10.1186/s12885-025-15183-9↗
- Treatment Strategies and Outcomes for Single-Site Recurrent Pancreatic Ductal Adenocarcinoma After Curative-Intent Surgery: Local Therapies are Associated with… Co-author DOI 10.1245/s10434-026-19939-w↗
- ASO Visual Abstract: Treatment Strategies and Outcomes for Single-Site Recurrent Pancreatic Ductal Adenocarcinoma After Curative-Intent Surgery: Local Therapie… Co-author DOI 10.1245/s10434-026-19987-2↗
- Complications following upfront pancreatectomy with venous resection do not compromise adjuvant chemotherapy delivery and survival in pancreatic cancer. Co-author DOI 10.1007/s00423-025-03933-z↗
- The Importance of Reading the Skin: Cutaneous Metastases of Pancreatic Cancer, a Systematic Review. Co-author DOI 10.3390/jcm13010104↗
Closest collaborators
The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Giampaolo Perri · 6 shared papers, 2023–2026 · strength 1.65
- Paper The projected rise of pancreatic cancer mortality in Italy: forecasts until 2035. DOI 10.1007/s13304-026-02862-w↗
- Paper Treatment Strategies and Outcomes for Single-Site Recurrent Pancreatic Ductal Adenocarcinoma After Curative-Intent Surg… DOI 10.1245/s10434-026-19939-w↗
- Paper ASO Visual Abstract: Treatment Strategies and Outcomes for Single-Site Recurrent Pancreatic Ductal Adenocarcinoma After… DOI 10.1245/s10434-026-19987-2↗
- Giovanni Marchegiani · 6 shared papers, 2023–2026 · strength 1.65
- Paper The projected rise of pancreatic cancer mortality in Italy: forecasts until 2035. DOI 10.1007/s13304-026-02862-w↗
- Paper Treatment Strategies and Outcomes for Single-Site Recurrent Pancreatic Ductal Adenocarcinoma After Curative-Intent Surg… DOI 10.1245/s10434-026-19939-w↗
- Paper ASO Visual Abstract: Treatment Strategies and Outcomes for Single-Site Recurrent Pancreatic Ductal Adenocarcinoma After… DOI 10.1245/s10434-026-19987-2↗
- Samuele Grandi · 3 shared papers, 2025–2026 · strength 0.87
- Paper The projected rise of pancreatic cancer mortality in Italy: forecasts until 2035. DOI 10.1007/s13304-026-02862-w↗
- Paper Conversion surgery vs. standard of care in pancreaTic cancer oligometastatic to the liver (SONAR: Surgery in Oligometas… DOI 10.1186/s12885-025-15183-9↗
- Paper Complications following upfront pancreatectomy with venous resection do not compromise adjuvant chemotherapy delivery a… DOI 10.1007/s00423-025-03933-z↗
- Aya Maekawa · 2 shared papers, 2026 · strength 0.60
- Paper Treatment Strategies and Outcomes for Single-Site Recurrent Pancreatic Ductal Adenocarcinoma After Curative-Intent Surg… DOI 10.1245/s10434-026-19939-w↗
- Paper ASO Visual Abstract: Treatment Strategies and Outcomes for Single-Site Recurrent Pancreatic Ductal Adenocarcinoma After… DOI 10.1245/s10434-026-19987-2↗
- Agata Grochowska · 2 shared papers, 2026 · strength 0.60
- Paper Treatment Strategies and Outcomes for Single-Site Recurrent Pancreatic Ductal Adenocarcinoma After Curative-Intent Surg… DOI 10.1245/s10434-026-19939-w↗
- Paper ASO Visual Abstract: Treatment Strategies and Outcomes for Single-Site Recurrent Pancreatic Ductal Adenocarcinoma After… DOI 10.1245/s10434-026-19987-2↗
- Riccardo Guastella · 2 shared papers, 2025–2026 · strength 0.49
- Paper Conversion surgery vs. standard of care in pancreaTic cancer oligometastatic to the liver (SONAR: Surgery in Oligometas… DOI 10.1186/s12885-025-15183-9↗
- Paper Complications following upfront pancreatectomy with venous resection do not compromise adjuvant chemotherapy delivery a… DOI 10.1007/s00423-025-03933-z↗
- Patrick Maisonneuve · 1 shared paper, 2026 · strength 0.39
- Letizia Procaccio · 1 shared paper, 2026 · strength 0.26
- Sara Lonardi · 1 shared paper, 2026 · strength 0.26
- Francesca Bergamo · 1 shared paper, 2026 · strength 0.26
- Zipeng Lu · 1 shared paper, 2025 · strength 0.23
- Kuirong Jiang · 1 shared paper, 2025 · strength 0.23
- Elio Jovine · 1 shared paper, 2023 · strength 0.17
- Fortunato Cassalia · 1 shared paper, 2023 · strength 0.17
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.